Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woong Gil Choi

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
JAMA|June 26, 2019
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical TrialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
JAMA Cardiology|September 28, 2022
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical TrialKi Hong Choi, Yong Hwan Park, Young Bin Song, et al.
Heart (British Cardiac Society)|March 24, 2021
P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitorJuwon Kim, Woo Jin Jang, Wang Soo Lee, et al.
Journal of the American Heart Association|December 21, 2020
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE TrialKyeong Ho Yun, Seung-Yul Lee, Byung Ryul Cho, et al.
American Heart Journal|February 8, 2023
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trialSoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Cardiology Journal|September 15, 2021
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Joo-Yong Hahn, Ju-Hyeon Oh, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
JAMA|June 26, 2019
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical TrialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
JAMA Cardiology|September 28, 2022
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical TrialKi Hong Choi, Yong Hwan Park, Young Bin Song, et al.
Heart (British Cardiac Society)|March 24, 2021
P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitorJuwon Kim, Woo Jin Jang, Wang Soo Lee, et al.
Journal of the American Heart Association|December 21, 2020
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE TrialKyeong Ho Yun, Seung-Yul Lee, Byung Ryul Cho, et al.
American Heart Journal|February 8, 2023
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trialSoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Cardiology Journal|September 15, 2021
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Joo-Yong Hahn, Ju-Hyeon Oh, et al.
Pageof 7